Top

Published in:

01-02-2021 | Human Papillomavirus | Original Paper

Cancer Incidence and Cancer Screening Practices Among a Cohort of Persons Receiving HIV Care in Washington, DC

Authors: Amanda Blair Spence, Matthew E. Levy, Anne Monroe, Amanda Castel, Joseph Timpone, Michael Horberg, Lucile Adams-Campbell, Princy Kumar

Published in: Journal of Community Health | Issue 1/2021

Abstract

In this era of effective combination antiretroviral therapy the incidence of AIDS defining cancers (ADCs) is projected to decline while the incidence of certain non-AIDS defining cancers (NADCs) increases. Some of these NADCs are potentially preventable with appropriate cancer screening. We examined cancer incidence, screening eligibility, and receipt of screening among persons actively enrolled in the DC Cohort, a longitudinal observational cohort of PLWH, between 2011 and 2017. Cancer screening eligibility was determined based on age, sex, smoking history and co-morbidity data available and published national guidelines. The incidence rate of NADCs was 12.1 (95% CI 10.7, 13.8) and ADCs 1.6 (95% CI 0.6, 4.6) per 1000 person-years. The most common incident NADCs were breast 2.6 (95% CI 0.5,1 2.1), prostate 2.3 (95% CI 1.2, 4.3), and non-melanoma skin 1.2 (95% CI 0.6, 2.3) incident diagnoses/cases per 1000 person-years. Among cohort sites where receipt of cancer screening was assessed, less than 60% of eligible participants had any ascertained anal HPV, breast, cervical, colorectal, hepatocellular carcinoma, or lung cancer screening. In this cohort of PLWH, there were more incident NADCs versus ADCs in contrast to earlier cohort studies where ADCs predominated. Despite a large eligible population there were low rates of screening. Implementation of cancer screening is an important component of care among PLWH.

Collaboration, A. T. C. (2017). Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. The Lancet HIV, 4(8), e349–e356.CrossRef

Porter, K., Babiker, A., Bhaskaran, K., Darbyshire, J., Pezzotti, P., Porter, K., et al. (2003). Determinants of survival following HIV-1 seroconversion after the introduction of HAART. The Lancet, 362(9392), 1267–1274.CrossRef

Smith, C. J., Ryom, L., Weber, R., Morlat, P., Pradier, C., Reiss, P., & D:A:D Study Group. (2014). Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration. The Lancet, 384(9939), 241–248.CrossRef

Centers for Disease Control and Prevention. (2017). HIV Surveillance Report, 2016; 28. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.

Marcus, J. L., Chao, C. R., Leyden, W. A., Xu, L., Quesenberry, C. P., Jr., Klein, D. B., et al. (2016). Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. Journal of Acquired Immune Deficiency Syndromes, 73(1), 39–46.PubMedCrossRef

Kochanek KD, Murphy SL, Xu JQ, Arias E. (2017). Mortality in the United States, 2016. NCHS Data Brief, no 293. https://www.cdc.gov/nchs/products/databriefs/db293.htm.

Riedel, D. J., Tang, L. S., & Rositch, A. F. (2015). The role of viral co-infection in HIV-associated non-AIDS-related cancers. Current HIV/AIDS Reports, 12(3), 362–372.PubMedPubMedCentralCrossRef

Hernández-Ramírez, R. U., Shiels, M. S., Dubrow, R., & Engels, E. A. (2017). Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. The Lancet HIV. https://doi.org/10.1016/S2352-3018(17)30125-X.PubMedPubMedCentralCrossRef

Yarchoan, R., & Uldrick, T. S. (2018). HIV-associated cancers and related diseases. The New England Journal of Medicine, 378(11), 1029–1041.PubMedPubMedCentralCrossRef

Shiels, M. S., Islam, J. Y., Rosenberg, P. S., Hall, H. I., Jacobson, E., & Engels, E. A. (2018). Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the united states through 2030. Annals of Internal Medicine, 168(12), 866–873.PubMedPubMedCentralCrossRef

Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P., Zingman, B. S., & Horberg, M. A. et al. (2014). Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases, 58(1), 1–10.PubMedCrossRef

Greenberg, A. E., Hays, H., Castel, A. D., Subramanian, T., Happ, L. P., & Jaurretche, M., et al. (2016). Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions. Journal of the American Medical Informatics Association, 23(3), 635–643.PubMedCrossRef

Siu, A. L. (2016). Screening for breast cancer: US preventive services task force recommendation statement. Annals of Internal Medicine., 164(4), 279–296.PubMedCrossRef

Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K.-M., Hwang, J. P., Jonas, M. M., et al. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 67(4), 1560–1599.PubMedCrossRef

Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., et al. (2018). AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology, 67(1), 358–380.PubMedCrossRef

Yuan, Y. (2011). Multiple imputation using SAS software. Journal of Statistical Software, 45(6), 1–25.CrossRef

Hessol, N. A., Seaberg, E. C., Preston-Martin, S., Massad, L. S., Sacks, H. S., & Silver, S., et al. (2004). Cancer risk among participants in the women’s interagency HIV study. Journal of Acquired Immune Deficiency Syndromes, 36(4), 978–985.PubMedCrossRef

Park, L. S., Tate, J. P., Rodriguez-Barradas, M. C., Rimland, D., Goetz, M. B., Gibert, C., et al. (2014). Cancer incidence in HIV-infected versus uninfected veterans: comparison of cancer registry and ICD-9 code diagnoses. Journal of AIDS & Clinical Research, 5(7), 1000318.

Seaberg, E. C., Wiley, D., Martínez-Maza, O., Chmiel, J. S., Kingsley, L., & Tang, Y., et al. (2010). Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer, 116(23), 5507–5516.PubMedCrossRef

Silverberg, M. J., Lau, B., Achenbach, C. J., Jing, Y., Althoff, K. N., D’Souza, G., Engels, E. A., Hessol, N. A., Brooks, J. T., Burchell, A. N., Gill, M. J., Goedert, J. J., Hogg, R., Horberg, M. A., Kirk, G. D., Kitahata, M. M., Korthuis, P. T., Mathews, W. C., Mayor, A., … North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS. (2015). Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Annals of Internal Medicine, 163(7), 507–518.

SEER Research Data 1973–2015. (n.d.). Retrieved September 6, 2018, from https://seer.cancer.gov/statfacts/html/all.html.

Omland, S. H., Ahlström, M. G., Gerstoft, J., Pedersen, G., Mohey, R., Pedersen, C., et al. (2018). Risk of skin cancer in patients with HIV: A Danish nationwide cohort study. Journal of the American Academy of Dermatology, 79(4), 689–695.PubMedCrossRef

Silverberg, M. J., Leyden, W., Warton, E. M., Quesenberry, C. P., Jr., Engels, E. A., & Asgari, M. M. (2013). HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. Journal of the National Cancer Institute, 105(5), 350–360.PubMedPubMedCentralCrossRef

Zhao, H., Shu, G., & Wang, S. (2016). The risk of non-melanoma skin cancer in HIV-infected patients: New data and meta-analysis. International Journal of STD & AIDS, 27(7), 568–575.CrossRef

Beachler, D. C., & DʼSouza, G., (2013). Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Current Opinion in Oncology, 25(5), 503–510.PubMedPubMedCentralCrossRef

Workowski, K. A., and G. A. Bolan. (2015). Sexually transmitted diseases treatment guidelines. MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports, 64, RR–03.

The Anchor Study. (n.d.). Retrieved January 28, 2019, from https://anchorstudy.org/.

Cervical Cancer Screening. (n.d.). Retrieved November 1, 2018, from https://progressreport.cancer.gov/detection/cervical_cancer.

Leece, P., Kendall, C., Touchie, C., Pottie, K., Angel, J. B., & Jaffey, J. (2010). Cervical cancer screening among HIV-positive women. Retrospective cohort study from a tertiary care HIV clinic. Canadian Family Physician Medecin de Famille Canadien, 56(12), e425–e431.PubMedPubMedCentral

Rahangdale, L., Sarnquist, C., Yavari, A., Blumenthal, P., & Israelski, D. (2010). Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States. Journal of Women’s Health, 19(4), 709–712.PubMedPubMedCentralCrossRef

Simonsen, S. E., Kepka, D., Thompson, J., Warner, E. L., Snyder, M., & Ries, K. M. (2014). Preventive health care among HIV positive women in a Utah HIV/AIDS clinic: A retrospective cohort study. BMC Women’s Health, 14(1), 37.PubMedPubMedCentralCrossRef

Goedert, J. J., Schairer, C., McNeel, T. S., Hessol, N. A., Rabkin, C. S., Engels, E. A. et al. (2006). Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. British Journal of Cancer, 95(5), 642–648.PubMedPubMedCentralCrossRef

Preston-Martin, S., Kirstein, L. M., Pogoda, J. M., Rimer, B., Melnick, S., Masri-Lavine, L., et al. (2002). Use of mammographic screening by HIV-infected women in the Women’s Interagency HIV Study (WIHS). Preventive Medicine, 34(3), 386–392.PubMedCrossRef

Breast Cancer Screening. (n.d.). Retrieved November 1, 2018, from https://progressreport.cancer.gov/detection/breast_cancer.

Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., et al. (2015). Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA, 314(15), 1599–1614.PubMedPubMedCentralCrossRef

Practice Bulletin, Number 179, July 2017, Breast Cancer Risk Assessment and Screening in Average-Risk Women. (n.d.). https://www.acog.org/-/media/Practice-Bulletins/Committee-on-Practice-Bulletins----Gynecology/Public/pb179.pdf?dmc=1&ts=20190108T2141432032.

Monticciolo, D. L., Newell, M. S., Hendrick, R. E., Helvie, M. A., Moy, L., Monsees, B., et al. (2017). Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging. Journal of the American College of Radiology: JACR, 14(9), 1137–1143.PubMedCrossRef

National Comprehensive Cancer Network. (2018). Breast Cancer Screening and Diagnosis. https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf.

McCormack, V. A., Febvey-Combes, O., Ginsburg, O., & Dos-Santos-Silva, I. (2018). Breast cancer in women living with HIV: A first global estimate. International Journal of Cancer, 143(11), 2732–2740.PubMedCrossRef

Moyer, V. A. & & U.S. Preventive Services Task Force. (2014). Screening for lung cancer: U.S. Preventive services task force recommendation statement. Annals of Internal Medicine, 160(5), 330–338.PubMedCrossRef

Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., Jr., García, F. A. R., et al. (2016). Screening for Colorectal Cancer: US preventive services task force recommendation statement. JAMA, 315(23), 2564–2575.PubMedCrossRef

Pham, D., Bhandari, S., Oechsli, M., Pinkston, C.M., Kloecker, G.H. James Graham Brown Cancer Center, University of Louisville, Louisville, KY, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, US, University of Louisville, Louisville, KY, University of Louisville School of Public Health, Information Sciences, Louisville, KY, University of Louisville School of Medicine, Department of Internal Medicine, Division of Hematology, & Medical Oncology, James Brown Graham Cancer Center, Louisville, KY. (2018). Lung cancer screening rates: Data from the lung cancer screening registry. https://meetinglibrary.asco.org/record/158432/abstract.

Lung Cancer Screening. (n.d.). Retrieved November 1, 2018, from https://progressreport.cancer.gov/detection/lung_cancer.

Centers for Disease Control and Prevention (CDC). Quick Facts: Colorectal Cancer Screening in U.S. (n.d.). https://www.cdc.gov/cancer/colorectal/pdf/QuickFacts-BRFSS-2016-CRC-Screening-508.pdf.

Keller, S. C., Momplaisir, F., Lo Re, V., Newcomb, C., Liu, Q., Ratcliffe, S. J., et al. (2014). Colorectal cancer incidence and screening in US Medicaid patients with and without HIV infection. AIDS Care, 26(6), 716–722.PubMedCrossRef

Horsky, J., Drucker, E. A., & Ramelson, H. Z. (2017). Accuracy and completeness of clinical coding using ICD-10 for ambulatory visits. AMIA ... Annual Symposium Proceedings/AMIA Symposium. AMIA Symposium, 2017, 912–920.

Title: Cancer Incidence and Cancer Screening Practices Among a Cohort of Persons Receiving HIV Care in Washington, DC
Authors: Amanda Blair Spence
Matthew E. Levy
Anne Monroe
Amanda Castel
Joseph Timpone
Michael Horberg
Lucile Adams-Campbell
Princy Kumar
Publication date: 01-02-2021
Publisher: Springer US
Keywords: Human Papillomavirus
Care
Human Immunodeficiency Virus
Acquired Immune Deficiency Syndrome
Published in: Journal of Community Health / Issue 1/2021
Print ISSN: 0094-5145
Electronic ISSN: 1573-3610
DOI: https://doi.org/10.1007/s10900-020-00844-6

At a glance: The STEP trials

Springer Medicine

Cancer Incidence and Cancer Screening Practices Among a Cohort of Persons Receiving HIV Care in Washington, DC

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Tobacco Research in the Eastern Mediterranean Region: A Scoping Review of Published Studies from Seven Countries

Community-Based Participatory Approach to Increase African Americans’ Access to Healthy Foods in Atlanta, GA

Mapping Food Insecurity-Related 2-1-1 Calls in a 10-County Area of Central Texas by Zip Code: Exploring the Role of Geographic Food Access, Urbanicity and Demographic Indicators

Promoting Community Health Worker Leadership in Policy Development: Results from a Louisiana Workforce Study

Socio-demographic, Health and Functional Status Correlates of Caregiver Burden Among Care Recipients Age 60 Years and Older in Jamaica

Routine Healthcare Utilization Among Reproductive-Age Women Residing in a Rural Maternity Care Desert